- Home
- LXP vs ITGR Comparison
LXP vs ITGR Comparison
Compare LXP & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LXP | ITGR |
|---|---|---|
| Founded | 1993 | 1970 |
| Country | United States | United States |
| Employees | 58 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.1B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | LXP | ITGR |
|---|---|---|
| Price | $55.71 | $92.96 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $51.88 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 540.1K | 422.0K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 5.58% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | N/A | $1.69 |
| Revenue Next Year | $6.00 | $6.53 |
| P/E Ratio | ★ $26.35 | $200.31 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $7.64 | $62.00 |
| 52 Week High | $56.93 | $118.18 |
Technical Indicators
Market Signals| Indicator | LXP | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 57.20 | 52.57 |
| Support Level | $49.75 | $82.58 |
| Resistance Level | $56.93 | $95.48 |
| Average True Range (ATR) | 1.08 | 2.76 |
| MACD | -0.08 | 0.05 |
| Stochastic Oscillator | 52.79 | 55.41 |
Price Performance
Historical ComparisonAbout LXP LXP Industrial Trust (Maryland REIT)
LXP Industrial Trust is a real estate investment trust principally involved in the ownership of equity and debt investments in single-tenant properties and land throughout the United States. The majority of the revenue is earned through rental revenue.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.